Close

UPDATE: Roth Capital Downgrades Bionano Genomics (BNGO) to Neutral

December 4, 2020 4:35 AM EST Send to a Friend
(Updated - December 4, 2020 4:43 AM EST)

Roth Capital analyst Scott Henry downgraded Bionano Genomics (NASDAQ: BNGO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login